Tenax Therapeutics, Inc.
TENX
$6.00
-$0.04-0.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -150.42% | -139.63% | -128.26% | -107.00% | -57.57% |
| Total Depreciation and Amortization | -- | -- | -- | -84.11% | -89.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,905.35% | 1,824.34% | 431.24% | -15.49% | -19.10% |
| Change in Net Operating Assets | 118.19% | 404.39% | 3.74% | 477.24% | 1,867.28% |
| Cash from Operations | -73.26% | -77.76% | -150.86% | -94.13% | -49.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -92.86% | -92.86% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -97.06% | -97.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 50.85% | 31.38% | 19.74% | -690.40% | -9,358.33% |
| Issuance of Common Stock | 9,257,640.00% | 133,088.17% | 535.21% | 535.21% | -99.99% |
| Repurchase of Common Stock | -592.43% | -592.48% | -592.48% | -72.90% | -82.63% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 450.84% | 450.87% | 665.60% | 184.33% | 194.08% |
| Cash from Financing | 1,457.45% | 1,444.83% | 636.02% | 624.80% | -46.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,496.02% | 5,399.44% | 1,009.27% | 1,088.44% | -165.05% |